These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16185306)

  • 1. Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.
    Guarino MP; Carotti S; Sarzano M; Alloni R; Vanni M; Grosso M; Sironi G; Maffettone PL; Cicala M
    Neurogastroenterol Motil; 2005 Oct; 17(5):680-6. PubMed ID: 16185306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones.
    Jüngst C; Sreejayan N; Zündt B; Müller I; Spelsberg FW; Hüttl TP; Kullak-Ublick GA; del Pozo R; Jüngst D; von Ritter C
    Eur J Clin Invest; 2008 Sep; 38(9):634-9. PubMed ID: 18837739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic acid decreases viscosity and sedimentable fractions of gallbladder bile in patients with cholesterol gallstones.
    Fischer S; Müller I; Zündt BZ; Jüngst C; Meyer G; Jüngst D
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):305-11. PubMed ID: 15195895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ursodeoxycholic acid on inflammatory infiltrate in gallbladder muscle of cholesterol gallstone patients.
    Carotti S; Guarino MP; Cicala M; Perrone G; Alloni R; Segreto F; Rabitti C; Morini S
    Neurogastroenterol Motil; 2010 Aug; 22(8):866-73, e232. PubMed ID: 20426797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term ursodeoxycholic acid therapy is associated with reduced risk of biliary pain and acute cholecystitis in patients with gallbladder stones: a cohort analysis.
    Tomida S; Abei M; Yamaguchi T; Matsuzaki Y; Shoda J; Tanaka N; Osuga T
    Hepatology; 1999 Jul; 30(1):6-13. PubMed ID: 10385632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.
    Colecchia A; Mazzella G; Sandri L; Azzaroli F; Magliuolo M; Simoni P; Bacchi-Reggiani ML; Roda E; Festi D
    World J Gastroenterol; 2006 Sep; 12(33):5336-43. PubMed ID: 16981264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long term hydrophilic bile acid therapy on in vitro contraction of gallbladder muscle strips in patients with cholesterol gallstones.
    Mas MR; Comert B; Mas N; Yamanel L; Ozotuk H; Tasci I; Jazrawi RP
    World J Gastroenterol; 2007 Aug; 13(32):4336-9. PubMed ID: 17708607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Magnesium Trihydrate of Ursodeoxycholic Acid and Chenodeoxycholic Acid for Gallstone Dissolution: A Prospective Multicenter Trial.
    Hyun JJ; Lee HS; Kim CD; Dong SH; Lee SO; Ryu JK; Lee DH; Jeong S; Kim TN; Lee J; Koh DH; Park ET; Lee IS; Yoo BM; Kim JH
    Gut Liver; 2015 Jul; 9(4):547-55. PubMed ID: 26087862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of biliary dysfunction in the pathogenesis of gallstone disease].
    Il'chenko IA; Deliukina OV
    Eksp Klin Gastroenterol; 2011; (7):70-8. PubMed ID: 22364003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy.
    Venneman NG; Besselink MG; Keulemans YC; Vanberge-Henegouwen GP; Boermeester MA; Broeders IA; Go PM; van Erpecum KJ
    Hepatology; 2006 Jun; 43(6):1276-83. PubMed ID: 16729326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones.
    van de Heijning BJ; van de Meeberg PC; Portincasa P; Doornewaard H; Hoebers FJ; van Erpecum KJ; Vanberge-Henegouwen GP
    Dig Dis Sci; 1999 Jan; 44(1):190-6. PubMed ID: 9952243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromycin, a motilin agonist, increases postprandial gallbladder emptying during therapy with ursodeoxycholic acid.
    Neubrand M; Sauerbruch T
    Z Gastroenterol; 1998 Apr; 36(4):267-71. PubMed ID: 9612923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gallstone disease: Microlithiasis and sludge.
    Jüngst C; Kullak-Ublick GA; Jüngst D
    Best Pract Res Clin Gastroenterol; 2006; 20(6):1053-62. PubMed ID: 17127187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ursodeoxycholic acid reduces protein levels and nucleation-promoting activity in human gallbladder bile.
    Van Erpecum KJ; Portincasa P; Eckhardt E; Go PM; VanBerge-Henegouwen GP; Groen AK
    Gastroenterology; 1996 Apr; 110(4):1225-37. PubMed ID: 8613013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficiency of ursotherapy in cholesterol-associated pathology of the gallbladder].
    Il'chenko AA; Drozhzhina IuV
    Eksp Klin Gastroenterol; 2009; (8):96-101. PubMed ID: 20469685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tauroursodeoxycholic acid, ursodeoxycholic acid and gallbladder motility in gallstone patients and healthy subjects.
    Portincasa P; DiCiaula A; Palmieri V; Velardi A; Van Berge-Henegouwen GP; Palasciano G
    Ital J Gastroenterol; 1996; 28(2):111-3. PubMed ID: 8782006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
    Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
    J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-3 polyunsaturated fatty acid attenuates cholesterol gallstones by suppressing mucin production with a high cholesterol diet in mice.
    Kim JK; Cho SM; Kang SH; Kim E; Yi H; Yun ES; Lee DG; Cho HJ; Paik YH; Choi YK; Haam SJ; Shin HC; Lee DK
    J Gastroenterol Hepatol; 2012 Nov; 27(11):1745-51. PubMed ID: 22849613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between biliary and serum bile acids and response to ursodeoxycholic acid in patients with primary biliary cirrhosis.
    Lindor KD; Lacerda MA; Jorgensen RA; DeSotel CK; Batta AK; Salen G; Dickson ER; Rossi SS; Hofmann AF
    Am J Gastroenterol; 1998 Sep; 93(9):1498-504. PubMed ID: 9732932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.